Caxton Associates (New York)’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $480K | Buy |
5,203
+336
| +7% | +$31K | 0.02% | 338 |
|
2024
Q3 | $470K | Buy |
+4,867
| New | +$470K | 0.02% | 368 |
|
2023
Q3 | – | Sell |
-8,355
| Closed | -$566K | – | 461 |
|
2023
Q2 | $566K | Buy |
+8,355
| New | +$566K | 0.08% | 245 |
|
2022
Q3 | – | Sell |
-11,180
| Closed | -$499K | – | 505 |
|
2022
Q2 | $499K | Buy |
+11,180
| New | +$499K | 0.05% | 262 |
|
2019
Q2 | – | Sell |
-18,335
| Closed | -$852K | – | 414 |
|
2019
Q1 | $852K | Buy |
18,335
+8,045
| +78% | +$374K | 0.12% | 77 |
|
2018
Q4 | $505K | Buy |
10,290
+6,699
| +187% | +$329K | 0.08% | 112 |
|
2018
Q3 | $223K | Buy |
+3,591
| New | +$223K | 0.02% | 321 |
|